Axillary vs sentinel lymph node dissectionfor invasive breast cancer [2]
Journal
JAMA - Journal of the American Medical Association
Journal Volume
305
Journal Issue
22
Pages
2288-2289
Date Issued
2011
Author(s)
Abstract
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
SDGs
Other Subjects
antineoplastic agent; axillary lymph node extirpation; breast cancer; cancer adjuvant therapy; cancer recurrence; clinical practice; clinical trial (topic); disease free survival; human; intermethod comparison; letter; lymph node dissection; lymph node metastasis; optimal drug dose; overall survival; postoperative care; priority journal; recurrence free survival; sentinel lymph node dissection; sentinel lymph node metastasis; surgical approach; survival; adjuvant chemotherapy; axilla; breast tumor; drug administration; female; lymphadenectomy; note; reproducibility; sentinel lymph node biopsy; time; treatment outcome; Axilla; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Lymph Node Excision; Reproducibility of Results; Sentinel Lymph Node Biopsy; Time Factors; Treatment Outcome
Type
letter